#news #biotech Aradigm crashes after FDA panel votes down antibiotic

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Aradigm crashes after FDA panel votes down antibiotic .A FDA expert committee has voted against Aradigm’s inhaled formulation of ciprofloxacin. Most of the panel felt Aradigm failed to provide substantial evidence of the safety and efficacy of Linhaliq in delaying the first exacerbation in patients with chronic lung infections.

from FierceBiotech: Biotech http://ift.tt/2mnkmV1